Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve compr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BioDrugs
Asıl Yazarlar: Velayudhan, Jyoti, Chen, Yuh-feng, Rohrbach, Amanda, Pastula, Christina, Maher, Gwen, Thomas, Heather, Brown, Ryan, Born, Teresa L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2016
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972870/
https://ncbi.nlm.nih.gov/pubmed/27422671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-016-0185-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller